固体和血液恶性瘤中的瘤溶解综合征:早期检测和干预指南
Sijimol Mathew1, John Bourgeois2
1Sijimol Mathew.
Clinical journal of oncology nursing
|November 21, 2025
概括
瘤溶解综合征 (TLS) 是一种关键的瘤紧急情况,导致严重的代谢问题,如高尿酸和. 及时识别和管理对于患者的生存和预防并发症至关重要.
科学领域:
- 在瘤学瘤学.
- 腎臟病學 (nephrology) 是一種醫學專業.
- 关键护理医学 关键护理医学
背景情况:
- 瘤溶解综合征 (TLS) 是一种危及生命的瘤紧急情况.
- 它的特点是严重的代谢障碍,包括高尿血,高血,高酸血和低血.
- TLS通常与血液性恶性瘤有关.
研究的目的:
- 审查TLS的病理生理学,临床表现和管理策略.
- 突出早期诊断和干预对于预防严重并发症的重要性.
- 讨论当前的治疗指南和新兴的治疗方法.
主要方法:
- 对TLS现有研究和临床指南的文献综述.
- 分析与TLS管理相关的病例报告和临床试验数据.
- 综合有关诊断标准和治疗干预措施的信息.
主要成果:
- 在瘤细胞死亡后,TLS的特征是细胞内内容的快速释放.
- 代谢异常可能导致急性损伤,心律失常和发作.
- 用水解和尿酸降低剂的预防对于高危患者至关重要.
结论:
- 有效的TLS管理需要多学科的方法,包括瘤学家,病学家和重症监护医生.
- 早期识别风险因素,及时启动预防措施,可以显著减少TLS的发生率和严重程度.
- 需要继续进行研究,以优化TLS治疗并改善患者的治疗结果.
相关概念视频
01:27Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
02:57Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K